EI
IMVT icon

EAM Investors’s Immunovant IMVT Stock Holding History

EAM Investors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.9M Buy
+127,273
New +$3.88M 0.44% 107
2024
Q2 		– Sell
-69,241
Closed -$2.24M – 295
2024
Q1 		$2.24M Sell
69,241
-41,688
-38% -$1.52M 0.35% 136
2023
Q4 		$4.67M Buy
110,929
+8,409
+8% +$309K 0.83% 14
2023
Q3 		$3.93M Buy
102,520
+62,724
+158% +$1.42M 0.76% 11
2023
Q2 		$755K Buy
+39,796
New +$742K 0.14% 251
2021
Q1 		– Sell
-32,498
Closed -$1.5M – 389
2020
Q4 		$1.5M Sell
32,498
-2,895
-8% -$134K 0.25% 190
2020
Q3 		$1.25M Buy
+35,393
New +$1.06M 0.3% 153

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EAM Investors's IMVT Position: Q2 2026 in Review

EAM Investors opened a new position in Immunovant (IMVT) in Q2 2026: 127,273 shares worth $4.9M. The stake represents 0.44% of the portfolio and ranks #107 among its holdings. This is a return to the name: EAM Investors previously reported a position in IMVT as recently as Q1 2024.

EAM Investors first reported a position in IMVT in Q3 2020 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • EAM Investors held 127,273 shares of Immunovant worth $4.9M as of Q2 2026.
  • Immunovant was a new EAM Investors position in Q2 2026.
  • Immunovant made up 0.44% of EAM Investors's portfolio in Q2 2026, its #107 holding.
  • EAM Investors first reported a position in Immunovant in Q3 2020 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.